Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors

NEW YORK--(BUSINESS WIRE)--Bioenvision, Inc. (Nasdaq:BIVN) today announced that Dr. Andrew N. Schiff and Mr. Steven A. Elms have resigned from the Company’s Board of Directors effective as of July 13, 2007. These departures were anticipated following the closing of the tender offer contemplated by the agreement and plan of merger entered into on May 29, 2007 by the Company, Genzyme Corporation (Nasdaq: GENZ) and Wichita Bio Corporation, a wholly-owned subsidiary of Genzyme.

MORE ON THIS TOPIC